Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis

Author： Wu Bin   Li Te   Chen Huafeng   Shen Jinfang  

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.5, 2010-08, pp. : 592-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B

By Crowley S.J.  

PharmacoEconomics, Vol. 17, Iss. 5, 2000-05 ,pp. : 409-427

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Varenicline in Belgium, Compared with Bupropion, Nicotine Replacement Therapy, Brief Counselling and Unaided Smoking Cessation: A BENESCO Markov Cost-Effectiveness Analysis

By Annemans Lieven  

Clinical Drug Investigation, Vol. 29, Iss. 10, 2009-10 ,pp. : 655-665

Adis International

Access to resources Recommend Favorite

A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B

By Spackman D. Eldon   Veenstra David L.  

PharmacoEconomics, Vol. 26, Iss. 11, 2008-01 ,pp. : 937-949

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Prophylactic Lamivudine Use in Preventing Vertical Transmission of Hepatitis B Virus Infection

By Hung Hui-Fang  

PharmacoEconomics, Vol. 29, Iss. 12, 2011-12 ,pp. : 1063-1073

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of pharmacotherapy for autoimmune hepatitis

By Heneghan Michael A   Al-Chalabi Thawab   McFarlane Ian G  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 145-156

Informa Healthcare

Access to resources Recommend Favorite